Pigmentation Disorders Treatment Market

Pigmentation Disorders Treatment Market (Treatment - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion; Key Disease Indications - Hyperpigmentation (Melasma, Post-inflammatory Hyperpigmentation, Solar Lentigines), Hypopigmentation (Vitiligo, Albinism); End use - Hospitals, Aesthetic Clinics and Dermatology Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Pigmentation Disorders Treatment Market - Snapshot

Pigmentation is coloring. When the color of one’s skin is affected, it is called skin pigmentation disorder. Presence of melanin in skin gives the skin its color. Melanin is made by the special cells in the skin. When these cells become unhealthy or are damaged, it leaves impact on the production of melanin. Some of the pigmentation disorders attack the skin in some patches, whilst others leave undesirable impact on the entire body. Increased occurrences of skin disorders is likely to amplify growth opportunities for the global pigmentation disorders treatment market in the years to come.

An upgradation in the lifestyle of people together with augmented demand for skin lightening is likely to play an important role in propelling growth of the global pigmentation disorders treatment market in the years to come. In addition to that, availability of high disposable income and rise in the aging population is estimated to shoot up the demand for pigmentation disorders treatment.

Topical Treatment Procedures to Emerge as one of the Prominent Treatments

Some of the common types of pigmentation disorders comprise the below-mentioned

  • Albinism
  • Melasma
  • Vitiligo
  • Post-Inflammatory Hyperpigmentation (PIH) 

At present, topical treatment is dominating the global pigmentation disorders treatment market, thanks to the much better clinical outcomes in those patients who are affected with various kinds of pigmentation disorders. L-ascorbic acid, hydroquinone, and azelaic acid are some of the popular topical drugs available widely in the market.

There has been a growing prominence of chemical peels for the purpose of treatment of facial hyper-pigmentation disorders. In this procedure, chemical peels are dipped in chemicals and then are applied on face or on the targeted areas, hands, and neck to remove the dead skin cells. The removal of dead skin the triggers growth of new skin cells on the affected areas.

 Global Pigmentation Disorders Treatment Market - Snapshot

Pigmentation disorders include a large number of heterogeneous conditions that are usually characterized by altered melanocyte density, melanin concentration, or both, and result in altered pigmentation of the skin. Pigmentation disorders are of three types: hypopigmentation, depigmentation, or hyperpigmentation. Areas where pigmentation appears may be focal or diffuse. In hypopigmentation, pigments are decreased, whereas in depigmentation, pigments are completely lost, leaving the skin white. The most common disorders are melasma (hyperpigmentary) and vitiligo (hypopigmentary). The global pigmentation disorders treatment market was valued at around US$ 5,225 Mn in 2017 and is anticipated to expand at a CAGR of more than 6.8% from 2018 to 2026 to reach around US$ 9,268.6 Mn in 2026. Several factors such as augmented adoption of lasers in pigmentation disorders treatment, decrease in social taboos boosting acceptance of pigmentation disorders treatment measures, and increase in prevalence of pigmentation-related disorders are driving the global pigmentation disorders treatment market.

pigmentation disorders treatment market

After stringent restructuring of regulations against dermo-cosmetic products and services, companies have started focussing on efficacy and quality with high investments in R&D. This has ultimately helped boost technological development and emergence of new products, services, and devices in the pigmentation disorder treatment market. The products and services have been moderated by regulatory bodies and have minimal side effects.

Opportunities for introducing new products, services, and devices are high as the market consists of established players and their brands. However, the market is still in search of highly efficient products and portable and technologically advanced devices. Safety and efficacy are major concerns in the pigmentation disorders treatment market. Therefore, introduction of such products presents a window of opportunity for new players to enter the market and establish themselves. The appreciation of regulatory compliance is a major factor that contributes to the success or failure of treatments, thus affecting sales. Galderma launched the triple combination to improve compliance of its key product, Tri-luma. Increased patient and provider awareness is also likely to help increase patient share of many marketed therapies during the forecast period.

The pigmentation disorder treatment market has been segmented based on treatment, disease indication, end-user, and region. In terms of treatment, the topical drugs segment is estimated to account for a prominent share of the market. An increasing number of patients with pigmentation disorders are visiting dermatologists, and topical drugs are being prescribed to these patients. With an existing unmet need for better treatment armamentarium for severe, recalcitrant patients and an estimated drug-treated population that is expected to double over the next decade, topical drugs is an attractive segment for drug developers. This is expected to fuel commercial interest in the development of tropical drugs.

Based on disease indication, the vitiligo and melasma segment constituted a major share of the market in 2017. The segment is likely to expand at a significant growth rate as compared to other disease indication segments during the forecast period. Globally, the prevalence of vitiligo and melasma varies. Women are far more likely to be affected by melisma than men, and both sexes are affected equally by vitiligo. In pigmentation, inadequate patient compliance still remains a significant unmet need. This single factor has hindered the ability of patients to achieve maximum treatment benefit, given the therapeutic options currently available, and has resulted in multiple failed treatment attempts.

In terms of region, the global pigmentation disorder treatment market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The pigmentation disorders treatment market is dominated by Asia Pacific. The market in the region is likely gain market share and expand at a rapid pace during the forecast period. The market in Asia Pacific is likely to be boosted by an increase in population, awareness about pigmentation disorder treatments and products, and growing economies. Furthermore, the pigmentation disorder treatment market in emerging economies of the Middle East, Latin America, and Africa is anticipated to add to the growth of the global market.

Prominent players in the global pigmentation disorder treatment market include Bayer AG, ALLERGAN, Galderma S.A., SkinCeuticals, Pierre Fabre, EpiPharm AG, RXi Pharmaceuticals Corporation, Obagi Cosmeceuticals LLC, and Vivier Pharma. The prevalent trend in the market is the strategic acquisition of key dermatology products by Big Pharma. A notable event in 2009 involved the acquisition of Stiefel, a leading dermatology company, by GSK for US$ 3.6 Bn.

The global pigmentation disorders treatment market has been segmented as follows:

Treatment

  • Topical Drugs
  • Laser Therapy
  • Chemical Peels
  • Microdermabrasion
  • Phototherapy
  • Others

Disease Indication

  • Hypopigmentation
    • Vitiligo
    • Albinism
    • Others
  • Hyperpigmentation
    • Melasma
    • Post-inflammatory Hyperpigmentation
    • Solar Lentigines
    • Others

End-user

  • Hospitals
  • Aesthetic Clinics & Dermatology Centers
  • Others

Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia & New Zealand
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa

    Section 01 Preface
    1.1 Report Scope and Market Segmentation
    1.2 Research Highlights

    Section 02 Assumptions and Research Methodology
    2.1 Assumptions
    2.2 Research Methodology

    Section 03 Executive Summary
    3.1 Global Pigmentation Disorders Treatment Market Size (US$ Mn)
    3.2 Global Pigmentation Disorders Treatment Market Snapshot, 2017
    3.3 Global Pigmentation Disorders Treatment Market: Opportunity Map

    Section 04 Market Overview
    4.1 Overview
    4.2 Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, 2016–2026
    4.3 Global Pigmentation Disorders Treatment Market Outlook
    4.4 Global Pigmentation Disorders Treatment Market: Porter’s Five Forces Analysis
    4.5 Pigmentation Disorders Treatment Market: Pipeline Analysis
    4.6 Key Partnership & Acquisitions
    4.7 Policies and Regulations, by Region
    4.8 Disease Prevalence and Incidence Rate Globally

    Section 05 Market Dynamics
    5.1 Drivers
    5.2 Restraints
    5.3 Opportunity Analysis
    5.4 Opportunities
    5.5 Trends

    Section 06 Pigmentation Disorders Treatment Market Analysis, by Treatment
    6.1 Introduction
    6.2 Global Pigmentation Disorders Treatment Market Value Share Analysis, by Treatment
    6.3 Pigmentation Disorders Treatment Market Analysis, by Treatment
        6.3.1 Topical Drugs
        6.3.2 Laser Therapy
        6.3.3 Chemical Peels
        6.3.4 Microdermabrasion
        6.3.5 Phototherapy
        6.3.6 Others
    6.4 Pigmentation Disorders Treatment Market Attractiveness Analysis, by Treatment

    Section 07 Pigmentation Disorders Treatment Market Analysis, by Disease Indication
    7.1 Introduction
    7.2 Global Pigmentation Disorders Treatment Market Value Share Analysis, by Disease Indication
    7.3 Pigmentation Disorders Treatment Market Analysis, by Disease Indication
        7.3.1 Global Pigmentation Disorders Treatment Market Analysis, by Hypopigmentation
               7.3.1.1 Vitiligo
               7.3.1.2 Albinism
               7.3.1.3 Others
        7.3.2 Global Pigmentation Disorders Treatment Market Analysis, by Hyperpigmentation
               7.3.2.1 Melasma
               7.3.2.2 Post-inflammatory Pigmentation
               7.3.2.3 Solar Lentigines
               7.3.2.4 Others
    7.4 Pigmentation Disorders Treatment Market Attractiveness Analysis, by Disease Indication
    7.5 Pigmentation Disorders Treatment Market Attractiveness Analysis, by Hypopigmentation
    7.6 Pigmentation Disorders Treatment Market Attractiveness Analysis, by Hyperpigmentation

    Section 08 Pigmentation Disorders Treatment Market Analysis, by End-user
    8.1 Introduction
    8.2 Global Pigmentation Disorders Treatment Market Value Share Analysis, by End-user
    8.3 Pigmentation Disorders Treatment Market Analysis, by End-user
        8.3.1 Hospitals
        8.3.2 Aesthetic Clinics & Dermatology Centers
        8.3.3 Others
    8.4 Pigmentation Disorders Treatment Market Attractiveness Analysis, by End-user

    Section 09 Pigmentation Disorders Treatment Market Analysis, by Region
    9.1 Global Pigmentation Disorders Treatment Market Snapshot, by Country
    9.2 Global Pigmentation Disorders Treatment Market Value Share Analysis, by Region
    9.3 Pigmentation Disorders Treatment Market Forecast, by Region
        9.3.1 North America
        9.3.2 Europe
        9.3.3 Asia Pacific
        9.3.4 Latin America
        9.3.5 Middle East & Africa
    9.4 Pigmentation Disorders Treatment Market Attractiveness Analysis, by Region

    Section 10 North America Pigmentation Disorders Treatment Market Analysis
    10.1 Key Findings
    10.2 North America Pigmentation Disorders Treatment Market Overview
    10.3 North America Market Value Share Analysis, by Treatment
    10.4 North America Market Forecast, by Treatment
        10.4.1 Topical Drugs
        10.4.2 Laser Therapy
        10.4.3 Chemical Peels
        10.4.4 Microdermabrasion
        10.4.5 Phototherapy
        10.4.6 Others
    10.5 North America Market Value Share Analysis, by Disease Indication
    10.6 North America Market Forecast, by Disease Indication
        10.6.1 North America Market Forecast, by Hypopigmentation
               10.6.1.1 Vitiligo
               10.6.1.2 Albinism
               10.6.1.3 Others
        10.6.2 North America Market Forecast, by Hyperpigmentation
               10.6.2.1 Melasma
               10.6.2.2 Post-inflammatory Pigmentation
               10.6.2.3 Solar Lentigines
               10.6.2.4 Others
    10.7 North America Market Value Share Analysis, by End-user
    10.8 North America Market Forecast, by End-user
        10.8.1 Hospitals
        10.8.2 Aesthetic Clinics & Dermatology Centers
        10.8.3 Others
    10.9 Market Analysis, by Country
    10.10 Market Value Share Analysis, by Country
    10.11 Market Size (US$ Mn) Forecast, by Country, 2018–2026
        10.11.1 U.S.
        10.11.2 Canada
    10.12 Market Attractiveness Analysis
        10.12.1 By Treatment
        10.12.2 By Disease Indication
        10.12.3 By Disease Hypopigmentation
        10.12.4 By Disease Hyperpigmentation
        10.12.5 By End-user
        10.12.6 By Country

    Section 11 Europe Pigmentation Disorders Treatment Market Analysis
    11.1 Key Findings
    11.2 Europe Pigmentation Disorders Treatment Market Overview
    11.3 Europe Market Value Share Analysis, by Treatment
    11.4 Europe Market Forecast, by Treatment
        11.4.1 Topical Drugs
        11.4.2 Laser Therapy
        11.4.3 Chemical Peels
        11.4.4 Microdermabrasion
        11.4.5 Phototherapy
        11.4.6 Others
    11.5 Europe Market Value Share Analysis, by Disease Indication
    11.6 Europe Market Forecast, by Disease Indication
        11.6.1 Europe Market Forecast, by Hypopigmentation
               11.6.1.1 Vitiligo
               11.6.1.2 Albinism
               11.6.1.3 Others
        11.6.2 Europe Market Forecast, by Hyperpigmentation
               11.6.2.1 Melasma
               11.6.2.2 Post-inflammatory Pigmentation
               11.6.2.3 Solar Lentigines
               11.6.2.4 Others
    11.7 Europe Market Value Share Analysis, by End-user
    11.8 Europe Market Forecast, by End-user
        11.8.1 Hospitals
        11.8.2 Aesthetic Clinics & Dermatology Centers
        11.8.3 Others
    11.9 Market Analysis, by Country
    11.10 Market Value Share Analysis, by Country
    11.11 Market Size (US$ Mn) Forecast, by Country, 2018–2026
        11.11.1 Germany
        11.11.2 France
        11.11.3 U.K.
        11.11.4 Italy
        11.11.5 Spain
        11.11.6 Rest of Europe
    11.12 Market Attractiveness Analysis
        11.12.1 By Treatment Type
        11.12.2 By Disease Indication
        11.12.3 By Disease Hypopigmentation
        11.12.4 By Disease Hyperpigmentation
        11.12.5 By End-user
        11.12.6 By Country

    Section 12 Asia Pacific Pigmentation Disorders Treatment Market Analysis
    12.1 Key Findings
    12.2 Asia Pacific Pigmentation Disorders Treatment Market Overview
    12.3 Asia Pacific Market Value Share Analysis, by Treatment
    12.4 Asia Pacific Market Forecast, by Treatment
        12.4.1 Topical Drugs
        12.4.2 Laser Therapy
        12.4.3 Chemical Peels
        12.4.4 Microdermabrasion
        12.4.5 Phototherapy
        12.4.6 Others
    12.5 Asia Pacific Market Value Share Analysis, by Disease Indication
    12.6 Asia Pacific Market Forecast, by Disease Indication
        12.6.1 Asia Pacific Market Forecast, by Hypopigmentation
               12.6.1.1 Vitiligo
               12.6.1.2 Albinism
               12.6.1.3 Others
        12.6.2 Asia Pacific Market Forecast, by Hyperpigmentation
               12.6.2.1 Melasma
               12.6.2.2 Post-inflammatory Pigmentation
               12.6.2.3 Solar Lentigines
               12.6.2.4 Others
    12.7 Asia Pacific Market Value Share Analysis, by End-user
    12.8 Asia Pacific Market Forecast, by End-user
        12.8.1 Hospitals
        12.8.2 Aesthetic Clinics & Dermatology Centers
        12.8.3 Others
    12.9 Market Analysis, by Country
    12.10 Market Value Share Analysis, by Country
    12.11 Market Size (US$ Mn) Forecast, by Country, 2018–2026
        12.11.1 China
        12.11.2 Japan
        12.11.3 India
        12.11.4 Australia & New Zealand
        12.11.5 Rest of Asia Pacific
    12.12 Market Attractiveness Analysis
        12.12.1 By Treatment
        12.12.2 By Disease Indication
        12.12.3 By Disease Hypopigmentation
        12.12.4 By Disease Hyperpigmentation
        12.12.5 By End-user
        12.12.6 By Country

    Section 13 Latin America Pigmentation Disorders Treatment Market Analysis
    13.1 Key Findings
    13.2 Latin America Pigmentation Disorders Treatment Market Overview
    13.3 Latin America Market Value Share Analysis, by Treatment
    13.4 Latin America Market Forecast, by Treatment
        13.4.1 Topical Drugs
        13.4.2 Laser Therapy
        13.4.3 Chemical Peels
        13.4.4 Microdermabrasion
        13.4.5 Phototherapy
        13.4.6 Others
    13.5 Latin America Market Value Share Analysis, by Disease Indication
    13.6 Latin America Market Forecast, by Disease Indication
        13.6.1 Latin America Market Forecast, by Hypopigmentation
               13.6.1.1 Vitiligo
               13.6.1.2 Albinism
               13.6.1.3 Others
        13.6.1 Latin America Market Forecast, by Hyperpigmentation
               13.6.2.1 Melasma
               13.6.2.2 Post-inflammatory Pigmentation
               13.6.2.3 Solar Lentigines
               13.6.2.4 Others
    13.7 Latin America Market Value Share Analysis, by End-user
    13.8 Latin America Market Forecast, by End-user
        13.8.1 Hospitals
        13.8.2 Aesthetic Clinics & Dermatology Centers
        13.8.3 Others
    13.9 Market Analysis, by Country
    13.10 Market Value Share Analysis, by Country
    13.11 Market Size (US$ Mn) Forecast, by Country, 2018–2026
        13.11.1 Brazil
        13.11.2 Mexico
        13.11.3 Rest of Latin America
    13.12 Market Attractiveness Analysis
        13.12.1 By Treatment
        13.12.2 By Disease Indication
        13.12.3 By Disease Hypopigmentation
        13.12.4 By Disease Hyperpigmentation
        13.12.5 By End-user
        13.12.6 By Country

    Section 14 Middle East & Africa Pigmentation Disorders Treatment Market Analysis
    14.1 Key Findings
    14.2 Middle East & Africa Pigmentation Disorders Treatment Market Overview
    14.3 Middle East & Africa Market Value Share Analysis, by Treatment
    14.4 Middle East & Africa Market Forecast, by Treatment
        14.4.1 Topical Drugs
        14.4.2 Laser Therapy
        14.4.3 Chemical Peels
        14.4.4 Microdermabrasion
        14.4.5 Phototherapy
        14.4.6 Others
    14.5 Middle East & Africa Market Value Share Analysis, by Disease Indication
    14.6 Middle East & Africa Market Forecast, by Disease Indication
        14.6.1 Middle East & Africa Market Forecast, by Hypopigmentation
               14.6.1.1 Vitiligo
               14.6.1.2 Albinism
               14.6.1.3 Others
        14.6.2 Middle East & Africa Market Forecast, by Hyperpigmentation
               14.6.2.1 Melasma
               14.6.2.2 Post-inflammatory Pigmentation
               14.6.2.3 Solar Lentigines
               14.6.2.4 Others
    14.7 Middle East & Africa Market Value Share Analysis, by End-user
    14.8 Middle East & Africa Market Forecast, by End-user
        14.8.1 Hospitals
        14.8.2 Aesthetic Clinics & Dermatology Centers
        14.8.3 Others
    14.9 Market Analysis, by Country
    14.10 Market Value Share Analysis, by Country
    14.11 Market Size (US$ Mn) Forecast, by Country, 2018–2026
        14.11.1 GCC Countries
        14.11.2 South Africa
        14.11.3 Rest of Middle East & Africa
    14.12 Market Attractiveness Analysis
        14.12.1 By Treatment
        14.12.2 By Disease Indication
        14.12.3 By Disease Hypopigmentation
        14.12.4 By Disease Hyperpigmentation
        14.12.5 By End-user
        14.12.6 By Country

    Section 15 Competition Landscape
    15.1 Competition Matrix
    15.2 Pigmentation Disorders Treatment Market Share Analysis, by Company (2017)
    15.3 Company Profiles
        15.3.1 Bayer AG
               15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
               15.3.1.2 Product Portfolio
               15.3.1.3 SWOT Analysis
               15.3.1.4 Strategic Overview
               15.3.1.5 Financial Overview
        15.3.2 ALLERGAN
               15.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)
               15.3.2.2 Product Portfolio
               15.3.2.3 SWOT Analysis
               15.3.2.4 Strategic Overview
               15.3.2.5 Financial Overview
        15.3.3 Galderma S.A. (Nestle Skin Health S.A)
               15.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)
               15.3.3.2 Product Portfolio
               15.3.3.3 SWOT Analysis
               15.3.3.4 Strategic Overview
        15.3.4 SkinCeuticals
               15.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)
               15.3.4.2 Product Portfolio
               15.3.4.3 SWOT Analysis
               15.3.4.4 Strategic Overview
        15.3.5 Pierre Fabre
               15.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)
               15.3.5.2 Product Portfolio
               15.3.5.3 SWOT Analysis
               15.3.5.4 Strategic Overview
               15.3.5.5 Financial Overview
        15.3.6 EpiPharm AG
               15.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)
               15.3.6.2 Product Portfolio
               15.3.6.3 SWOT Analysis
               15.3.6.4 Strategic Overview
        15.3.7 RXi Pharmaceuticals Corporation
               15.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)
               15.3.7.2 Product Portfolio
               15.3.7.3 SWOT Analysis
               15.3.7.4 Strategic Overview
               15.3.7.5 Financial Overview
        15.3.8 Obagi Cosmeceuticals LLC (Obagi medical)
               15.3.8.1 Company Overview (HQ, Business Segments, Employee Strength)
               15.3.8.2 Product Portfolio
               15.3.8.3 SWOT Analysis
               15.3.8.4 Strategic Overview
        15.3.9 Vivier Pharma
               15.3.9.1 Company Overview (HQ, Business Segments, Employee Strength)
               15.3.9.2 Product Portfolio
               15.3.9.3 SWOT Analysis
               15.3.9.4 Strategic Overview

    List of Tables

    Table 01: Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
    Table 02: Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
    Table 03: Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hypopigmentation, 2016–2026
    Table 04: Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hyperpigmentation, 2016–2026
    Table 05: Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
    Table 06: Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Region, 2016–2026
    Table 07: North America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country, 2016–2026
    Table 08: North America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
    Table 09: North America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hypopigmentation, 2016–2026
    Table 10: North America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hyperpigmentation, 2016–2026
    Table 11: North America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
    Table 12: Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 13: Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
    Table 14: Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
    Table 15: Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hypopigmentation, 2016–2026
    Table 16: Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hyperpigmentation, 2016–2026
    Table 17: Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
    Table 18: Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 19: Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
    Table 20: Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
    Table 21: Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by hypopigmentation, 2016–2026
    Table 22: Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hyperpigmentation, 2016–2026
    Table 23: Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
    Table 24: Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 25: Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
    Table 26: Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
    Table 27: Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hypopigmentation, 2016–2026
    Table 28: Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hyperpigmentation, 2016–2026
    Table 29: Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
    Table 30: Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 31: Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
    Table 32: Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
    Table 33: Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hypopigmentation, 2016–2026
    Table 34: Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hyperpigmentation, 2016–2026
    Table 35: Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026

    List of Figures

    Figure 01: Global Pigmentation Disorders Treatment Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
    Figure 02: Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 03: Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017
    Figure 04: Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017
    Figure 05: Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017
    Figure 06: Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017
    Figure 07: Pigmentation Disorders Treatment Market Value Share, by End-user, 2017
    Figure 08: Pigmentation Disorders Treatment Market Value Share, by Region, 2017
    Figure 09: Global Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
    Figure 10: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Topical Drugs, 2016–2026
    Figure 11: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Laser Therapy, 2016–2026
    Figure 12: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemical Peels, 2016–2026
    Figure 13: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microdermabrasion, 2016–2026
    Figure 14: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Phototherapy, 2016–2026
    Figure 15: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
    Figure 16: Global Pigmentation Disorders Treatment Market Attractiveness Analysis, by Treatment, 2018–2026
    Figure 17: Global Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
    Figure 18: Global Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017 and 2026
    Figure 19: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitiligo, 2016–2026
    Figure 20: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Albinism, 2016–2026
    Figure 21: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
    Figure 22: Global Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017 and 2026
    Figure 23: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Melasma, 2016–2026
    Figure 24: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Post-inflammatory Hyperpigmentation, 2016–2026
    Figure 25: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Solar Lentigines, 2016–2026
    Figure 26: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
    Figure 27: Global Pigmentation Disorders Treatment Market Attractiveness Analysis, by Disease Indication, 2018–2026
    Figure 28 Global Pigmentation Disorders Treatment Market Attractiveness Analysis, by Hypopigmentation, 2018–2026
    Figure 29: Global Pigmentation Disorders Treatment Market Attractiveness Analysis, by Hyperpigmentation, 2018–2026
    Figure 30: Global Pigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
    Figure 31: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2016–2026
    Figure 32: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aesthetic Clinics & Dermatology Centers, 2016–2026
    Figure 33: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
    Figure 34: Global Pigmentation Disorders Treatment Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 35: Global Pigmentation Disorders Treatment Market Value Share, by Region, 2017 and 2026
    Figure 36: Global Pigmentation Disorders Treatment Market Attractiveness Analysis, by Region, 2018–2026
    Figure 37: North America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 38: North America Pigmentation Disorders Treatment Market Value Share, by Country, 2017 and 2026
    Figure 39: North America Pigmentation Disorders Treatment Market Attractiveness, by Country, 2018–2026
    Figure 40: North America Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
    Figure 41: North America Pigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
    Figure 42: North America Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
    Figure 43: North America Pigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
    Figure 44: North America Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017 and 2026
    Figure 45: North America Pigmentation Disorders Treatment Market Attractiveness, by Hypopigmentation, 2018–2026
    Figure 46: North America Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017 and 2026
    Figure 47: North America Pigmentation Disorders Treatment Market Attractiveness, by Hyperpigmentation, 2018–2026
    Figure 48: North America Pigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
    Figure 49: North America Pigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
    Figure 50: Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 51: Europe Pigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
    Figure 52: Europe Pigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
    Figure 53: Europe Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
    Figure 54: Europe Pigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
    Figure 55: Europe Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
    Figure 56: Europe Pigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
    Figure 57: Europe Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017 and 2026
    Figure 58: Europe Pigmentation Disorders Treatment Market Attractiveness, by Hypopigmentation, 2018–2026
    Figure 59: Europe Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017 and 2026
    Figure 60: Europe Pigmentation Disorders Treatment Market Attractiveness, by Hyperpigmentation, 2018–2026
    Figure 61: Europe Pigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
    Figure 62: Europe Pigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
    Figure 63: Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 64: Asia Pacific Pigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
    Figure 65: Asia Pacific Pigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
    Figure 66: Asia Pacific Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
    Figure 67: Asia Pacific Pigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
    Figure 68: Asia Pacific Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
    Figure 69: Asia Pacific Pigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
    Figure 70: Asia Pacific Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017 and 2026
    Figure 71: Asia Pacific Pigmentation Disorders Treatment Market Attractiveness, by Hypopigmentation, 2018–2026
    Figure 72: Asia Pacific Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017 and 2026
    Figure 73: Asia Pacific Pigmentation Disorders Treatment Market Attractiveness, by Hyperpigmentation, 2018–2026
    Figure 74: Asia Pacific Pigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
    Figure 75: Asia Pacific Pigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
    Figure 76: Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 77: Latin America Pigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
    Figure 78: Latin America Pigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
    Figure 79: Latin America Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
    Figure 80: Latin America Pigmentation Disorders Treatment Market Attractiveness, by Treatment Type, 2018–2026
    Figure 81: Latin America Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
    Figure 82: Latin America Pigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
    Figure 83: Latin America Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017 and 2026
    Figure 84: Latin America Pigmentation Disorders Treatment Market Attractiveness, by Hypopigmentation, 2018–2026
    Figure 85: Latin America Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017 and 2026
    Figure 86: Latin America Pigmentation Disorders Treatment Market Attractiveness, by Hyperpigmentation, 2018–2026
    Figure 87: Latin America Pigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
    Figure 88: Latin America Pigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
    Figure 89: Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 90: Middle East & Africa Pigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
    Figure 91: Middle East & Africa Pigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
    Figure 92: Middle East & Africa Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
    Figure 93: Middle East & Africa Pigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
    Figure 94: Middle East & Africa Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
    Figure 95: Middle East & Africa Pigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
    Figure 96: Middle East & Africa Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017 and 2026
    Figure 97: Middle East & Africa Pigmentation Disorders Treatment Market Attractiveness, by Hypopigmentation, 2018–2026
    Figure 98: Middle East & Africa Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017 and 2026
    Figure 99: Middle East & Africa Pigmentation Disorders Treatment Market Attractiveness, by Hyperpigmentation, 2018–2026
    Figure 100: Middle East & Africa Pigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
    Figure 101: Middle East & Africa Pigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026

Copyright © Transparency Market Research, Inc. All Rights reserved